Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03470688
- Collaborators
- Merck Sharp & Dohme Corp.
- Investigators
- Principal Investigator: Paul Bird Optimus Research
Get Well Soon